H aematopoietic stem cell (HSC) niches are present in diverse tissues throughout development, beginning in the aorta-gonadmesonephros (AGM) region and the yolk sac, followed by the placenta, fetal liver, spleen and bone marrow 1 . Postnatally, the bone marrow is the primary site of HSC maintenance and haematopoiesis, but in response to haematopoietic stress the niche can shift to extramedullary sites. Defining niche components and how they work in concert to regulate haematopoiesis provides the opportunity to improve regeneration following injury or HSC transplantation and to understand how disordered niche function could contribute to disease. In this Review, we focus on the nature of the HSC niche in bone marrow because it is the subject of most of the recent research and controversies.
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Historical context
Following Darwin's contributions to evolutionary theory, there was much emphasis on defining hierarchical evolutionary relationships among organisms. Morphological similarities were used to construct ancestral trees that connected complex multicellular organisms to an original monocellular "stem celle" 2 . Lineage relationships were formulated, and biologist Ernst Haeckel proposed that cell organization in a developing organism was the recapitulation of events in the evolution of the species, with cells deriving from a stem cell equivalent 3 . Thirty years later, haematologist Artur Pappenheim proposed a less grand and more accurate formulation based on improved cell-morphology visualization techniques -that cells of the blood were related to one another, with mature cell types descending from a single cell type in a "unified view of haematopoiesis" 4 . In so doing, he articulated the hypothesis of tissue stem cells. This concept took about half a century to define experimentally through the inspired work of James Till and Ernest McCulloch, who showed that single cells could yield multilineage descendants while preserving the multipotency of the mother cell [5] [6] [7] . The researchers gave substance to the idea of a stem cell and gave us methods to define the cardinal properties of those cells -self-renewal and differentiation.
Till and McCulloch based much of their work on an in vivo spleen colony-forming (CFU-S) assay now known to measure mainly multipotent progenitors rather than long-term self-renewing HSCs 8, 9 . The imprecise nature of that assay contributed to the formulation of the niche hypothesis by Ray Schofield in 1978. Recognizing that the putative CFU-S stem cells were less robust than cells of the bone marrow at reconstituting haematopoiesis in irradiated animals, he proposed that a specialized bone marrow niche preserved the reconstituting ability of stem cells 10 . His colleagues at the University of Manchester concurrently sought to define what made bone marrow a nurturing context for HSCs, and haematologist Michael Dexter showed that largely mesenchymal 'stromal' cell cultures could maintain primitive haematopoietic cells ex vivo 11 . Furthermore, another colleague, Brian Lord, progressively reamed long bone marrow cavities and showed that primitive cells tended to localize towards the endosteal margins, leading to the hypothesis that bone might regulate haematopoiesis 12 ( Fig. 1 ). These early studies were followed by in vitro evidence that osteoblasts differentiated in culture from human bone marrow stromal cells could produce haematopoietic cytokines and support primitive haematopoietic cells in culture 13 . This fostered the idea that bone cells might create the HSC niche, but it was essential to move to engineered mouse strains to test the hypothesis in vivo. Two studies followed, including a mouse model in which a promoter that was restricted in activity to osteoblastic cells was used to drive expression of a constitutively active parathyroid hormone receptor 14 . Along similar lines, Linheng Li's laboratory used a promoter that has since been shown to be restricted in bone marrow stroma to primitive and mature osteolineage cells 15 , to delete the BMPr1a gene 16 . In both models, the number of endosteal osteoblasts and the number of primitive haematopoietic cells (scored as stem cells given the measures in use at the time) increased. These data provided the first evidence of specific heterologous cells regulating mammalian stem cells in vivo, although it remained unclear whether the regulation was direct or indirect. This demonstrated that the niche was experimentally tractable, prompting a series of studies that have since refined our understanding of the complexity of the bone marrow microenvironment.
Studies of the niche have now more precisely determined the components that regulate HSCs, and to some extent other haematopoietic progenitors, in the bone marrow. Like any interactive system there are complex regulatory relationships among cells in the bone marrow. A perturbation in one cell type that leads to an effect in another cell type does not necessarily require the interaction between the cells to be direct. The data now suggest that the early studies that observed effects on HSC frequency as a consequence of genetic manipulation in osteoblastic cells reflected indirect effects rather than the existence of an osteoblastic niche. Indeed, expression of constitutively active parathyroid hormone receptors in osteoblasts 14 probably causes widespread changes in many cell types of the bone marrow, including in the vasculature. Current data suggest Niches are local tissue microenvironments that maintain and regulate stem cells. Haematopoiesis provides a model for understanding mammalian stem cells and their niches, but the haematopoietic stem cell (HSC) niche remains incompletely defined and beset by competing models. Recent progress has been made in elucidating the location and cellular components of the HSC niche in the bone marrow. The niche is perivascular, created partly by mesenchymal stromal cells and endothelial cells and often, but not always, located near trabecular bone. Outstanding questions concern the cellular complexity of the niche, the role of the endosteum and functional heterogeneity among perivascular microenvironments.
there are specialized niches for distinct types of haematopoietic stem and progenitor cells, and that each niche may be created by multiple cell types that contribute to the niches in unique as well as redundant ways 17 . Indeed, there is heterogeneity among HSCs themselves [18] [19] [20] , raising the possibility of cellularly distinct niches for distinct subpopulations of HSCs. This Review focuses on the current data and the unanswered questions.
Mapping the bone marrow space
A niche is defined by anatomy and function 21 -a local tissue microenvironment that directly maintains and regulates a particular kind of stem cell or progenitor 22 . Determining what cells neighbour HSCs and regulate HSC maintenance has been complicated by the difficulty in retaining histological integrity when sectioning bone, as well as the complexity of immunostaining methods that are necessary to identify HSCs.
The identification of markers that reliably identify HSCs in vivo was an important step in defining the niche 22 . Despite having the ability to isolate HSCs by flow cytometry for decades 23 , identifying HSCs within tissues has remained a challenge because the combination of immunofluorescent markers used to isolate HSCs by flow cytometry was too complex for microscopy. Consequently, markers of poor specificity were often used. For example, putative HSCs have been localized in the bone marrow using retention labels 5-bromodeoxyuridine (BrdU) or GFP-labelled histone H2B (H2B-GFP) as markers 24, 25 . Although there is a subset of HSCs that preferentially retains H2B-GFP and BrdU, these markers by themselves have very poor specificity -most bone marrow cells that retain these labels are not HSCs 18, 19, 26 . When positive staining for CD150 was combined with negative staining for CD48 and CD41, HSCs could finally be highly purified using a simple two-colour stain 27 . The sequential high-resolution imaging of mice assessed the threedimensional position of cells in the calvarium over time 32, 35 . These studies indicated that primitive haematopoietic cells trafficked to specific microdomains of bone marrow blood vessels where the key HSC localization chemokine CXCL12 and the glycoprotein E-selectin were abundant, then remained in these positions for weeks, generating new cells as indicated by the partitioning of a cytosolic dye. When HSCs were visualized after transplantation into irradiated mice they preferentially localized near the endosteum, consistent with that region being particularly relevant for HSC maintenance 32, 36 . However, it was subsequently found that irradiation disrupts sinusoids in the bone marrow 37 , raising the possibility that the only blood vessels preserved after irradiation are the arteriolar vessels near the endosteum. Therefore, the peri-endosteal localization of HSCs in these experiments may have reflected, in part, the destruction of sinusoidal niches by irradiation. Overall, the localization data emphasized the possibility of a perivascular niche. How could this be resolved with historical data suggesting that the endosteum and osteoblasts were niche participants?
Osteoblasts are more harbinger than host
Although osteoblastic cells were the first cell population shown to influence haematopoietic stem or progenitor cell frequency when perturbed in vivo 14, 16 , several lines of evidence raised concerns that the effect may not be direct. First, in vivo imaging studies using validated markers or labelled stem cells found few HSCs in contact with osteoblastic cells 27, 31, 32, 33, 38 . Second, studies that depleted osteoblasts by Bgn deficiency 30 or osteoblastic cells by treatment with ganciclovir 39, 40 or that increased osteoblasts by strontium treatment 41 had no acute effect on HSC frequency. The studies in which osteoblastic cells were conditionally deleted by ganciclovir showed acute depletion of B lymphoid progenitors and only later showed a decline in a stem/progenitor cell population 39, 40 . Third, genetic modification of primitive osteolineage cells had an effect on HSC proliferation and differentiation, but the same modification in mature osteoblasts did not 42 . Finally, a key adhesion molecule thought to mediate osteoblast-HSC interaction, N-cadherin, was called into question.
N-cadherin + HSCs were proposed to adhere to N-cadherin + osteoblasts by homophilic adhesion 16, 36 , promoting HSC maintenance [43] [44] [45] ; however, these studies did not test whether deletion of the gene that encodes N-cadherin (Cdh2) affected HSC function. The levels of N-cadherin staining in HSCs were difficult to distinguish from background fluorescence and depended on anti-N-cadherin antibodies that gave nonspecific staining in some haematopoietic cells . Conditional deletion of Cdh2 from HSCs or from osteoblast lineage cells had no effect on HSC frequency, HSC function or haematopoiesis 38, 49, 50 . Collectively, these data undermined the notion of an N-cadherin + 'osteoblastic' niche. Is there any role for osteoblasts or osteolineage cells in HSC regulation? Several lines of evidence suggest that this possibility remains viable but not as it was initially foreseen. First, higher numbers of HSCs reside in the trabecular rich metaphysis 31, 51 . This may simply reflect other components of bone marrow co-localizing with bony surfaces; however, conditional deletion of Sp7 (Osterix) results in chondrocytes without osteoblastic differentiation, increasing blood vessels and mesenchymal progenitors in the These data argue that the presence of mature or maturing osteolineage cells in regions with abundant endosteum is crucial for haematopoiesis. Indeed, mesenchymal progenitors that are capable of forming bone are sufficient to create bony ossicles that become invested by host vasculature and HSCs 53, 54 . This suggests that bone or bone-forming progenitors can promote the formation or maintenance of HSC niches (for example by recruiting vasculature to the bone marrow) even if they do not directly promote HSC maintenance.
Transplanted haematopoietic stem or progenitor cells preferentially localize to blood vessels in endosteal regions even without prior cytotoxic conditioning 55 . Within the endosteal region, transplanted HSCs position themselves closer to the endosteal surface than progenitor cells 32 . These may again reflect indirect effects of bone-forming osteolineage cells as bone turnover results in high local concentrations of ionic calcium, and the calcium-sensing receptor promotes bone marrow engraftment by HSCs during development or after transplantation 56 . Osteolineage cells also elaborate cytokines and extracellular matrix proteins that may influence a wide range of cell types, some of which may directly regulate HSC function. This is exemplified by parathyroid hormone receptor activation, which induces expression of multiple regulatory molecules (such as IL-6, RANKL and Jagged1) by osteoblasts that can influence other cells in the bone marrow, including the vasculature 14, 57 . In addition, osteoblastic expression of transgenes encoding the Wnt antagonists Dkk1 and Wif1 depletes HSCs 58, 59 . Finally, the depletion of osteocalcin-expressing cells (osteoblasts or osteocytes) in vivo results in an inability to mobilize at least short-term repopulating cells to the blood using granulocyte colony-stimulating factor 60,61 despite osteoblasts having little expression of CXCL12 (refs 17, 33, 62) . In aggregate, these data indicate that the endosteal region is important for haematopoiesis, but the mature osteolineage cells probably have an indirect role in modulating HSCs. However, these cells seem to be more important in directly regulating restricted progenitors, a topic discussed later. It is important, therefore, to refocus attention on the endosteum as a regulatory region and not on the osteoblasts themselves (Fig. 3) .
The endosteum has a diverse group of cells and anatomical elements, including a rich endowment of arteriolar and sinusoidal blood vessels 31, 32 ( Fig. 1) . The cells include endothelial cells as well as mesenchymal cells with osteolineage potential. These mesenchymal cells reside perivascularly but traffic to the endosteal surface to differentiate into osteoblasts. Undifferentiated mesenchymal cells around blood vessels may promote HSC maintenance throughout the bone marrow, but the mesenchymal cells around vessels in the endosteal region may differ from those distant from endosteal surfaces.
Perivascular regulators of HSCs
Given the localization of HSCs near blood vessels, it was crucial to define the stromal cells surrounding the vessels and to test whether they promote HSC maintenance. Attention focused on the mesenchymal cells that surround blood vessels throughout the bone marrow. Although mesenchymal stroma are likely to be heterogeneous, and the precise relationships between cells expressing various markers remain to be defined, perivascular mesenchymal cells that express CD146 in humans 54 + skeletal stem cells also localize adjacent to sinusoids in the bone marrow and synthesize high levels of the HSC niche factors stem cell factor (SCF) and CXCL12 (ref. 54).
The possibility that mesenchymal stem or stromal cells (MSCs) are part of the HSC niche was further supported by the finding that MSCs in the bone marrow express a Nes-GFP transgene and localize around blood vessels throughout the bone marrow 63 . HSCs commonly localize adjacent to Nes-GFP + cells and these cells express high levels of Scf and Cxcl12. Moreover, fibroblast activation protein (FAP) is expressed by bone marrow stromal cells that have many characteristics of MSCs, including Cxcl12, Scf, Pdgfrα and Sca-1 expression 66, 67 , and ablation of these FAP + cells leads to bone marrow hypocellularity, anaemia and depletion of osteogenic cells 68, 69 . These studies provided strong evidence that MSCs are one component of a perivascular niche for HSCs.
Endothelial cells also contribute to the perivascular HSC niche 27 . The earliest functional evidence supporting this possibility was the observation that conditional deletion of the gene that encodes the gp130 cytokine receptor in endothelial cells led to bone marrow hypocellularity and a reduction in HSC numbers 70 . Inhibition of VEGFR2 signalling in irradiated mice using a blocking antibody impaired the regeneration of sinusoidal endothelial cells and prevented the recovery of LSK stem or progenitor cells as well as CFU-S cells 37 . Endothelial cells can promote HSC maintenance in culture 71 , and bone marrow sinusoidal endothelial cells promote long-term reconstituting HSC expansion in culture 72, 73 . It has been suggested that E-selectin is exclusively expressed by endothelial cells in the bone marrow, and deficiency of the gene that encodes it renders HSCs more quiescent and resistant to irradiation 74 . These studies suggested that endothelial cells are one component of the HSC niche, but did not address whether they directly or indirectly regulate HSC maintenance in vivo. . It is likely that other cells also contribute to this niche, these probably include cells near bone surfaces in trabecular-rich areas. Other cell types that regulate HSC niches include sympathetic nerves 91, 92 , non-myelinating Schwann cells (which are also Nes + ) 96 , macrophages 95 and osteoclasts 97 . The extracellular matrix 120, 121 and calcium 56 also regulate HSCs. Osteoblasts do not directly promote HSC maintenance but do promote the maintenance and perhaps the differentiation of certain lymphoid progenitors by secreting CXCL12 and probably other factors 13, 17, 39, 40 . Early lymphoid restricted progenitors thus reside in an endosteal niche that is spatially and cellularly distinct from HSCs.
To formally identify the niche cells, researchers examined which cell populations were the key sources of factors that promote HSC maintenance in vivo. For example, SCF has a non-cell-autonomous role for HSC maintenance in vivo [75] [76] [77] [78] [79] . 82 . Because cell-cell contact is needed between HSCs and those that synthesize SCF, the niche could be localized by identifying the key sources of SCF for HSC maintenance.
Analysis of the Scf expression pattern in mice in which GFP is knocked in to the Scf locus revealed that Scf is expressed perivascularly, mainly around sinusoids throughout the bone marrow . These results proved there is a perivascular niche for HSCs in which endothelial cells and mesenchymal cells promote HSC maintenance by synthesizing SCF (Fig. 3) .
It has been proposed that the endosteal region and its osteoblastic cells provide a unique zone for the maintenance of quiescent HSCs. However, when Scf was conditionally deleted from both endothelial cells and Are other key niche factors also synthesized primarily by perivascular cells? Cxcl12 is a chemokine that is required for HSC maintenance and HSC retention in the bone marrow 33, [83] [84] [85] [86] . Global deletion of Cxcl12, or the gene that encodes the Cxcl12 receptor, Cxcr4, depletes HSCs from the bone marrow 33, 83, 87 . Cxcl12 is primarily expressed by perivascular mesenchymal stromal cells (CAR cells, Nes-GFP, Lepr-Cre or Prx1-Cre expressing cells), with 100-fold lower levels of expression in endothelial cells and 1,000-fold lower levels in osteoblasts 17, 33, 62, 88, 89 . Conditional deletion of Cxcl12 from perivascular mesenchymal cells using Prx1-Cre and Lepr-Cre depleted and mobilized HSCs, respectively 17, 62 . HSCs were depleted but not mobilized when Cxcl12 was conditionally deleted from endothelial cells (Tie2-Cre) 17, 62 . HSC frequency and bone marrow retention were not affected when Cxcl12 was conditionally deleted from osteoblasts or their progenitors (Col2.3-Cre and Sp7-Cre), haematopoietic cells (Vav1-Cre), or Nes-Cre-expressing stromal cells 17, 62 . These data confirmed that HSCs reside in a perivascular niche in which mesenchymal stromal cells and endothelial cells each synthesize multiple factors that promote HSC maintenance and localization.
Although 
Complexity of the perivascular HSC niche
Endothelial cells and mesenchymal stromal cells are not the only cell types that regulate the perivascular HSC niche (Fig. 3) . The sympathetic nervous system regulates CXCL12 expression and HSC retention in the bone marrow 91, 92 . This seems to be accomplished by sympathetic nerve fibres that likely synapse on perivascular cells around a subset of blood vessels in the bone marrow, conferring circadian regulation of CXCL12 expression and HSC mobilization. Circadian oscillation in the clearance of aged neutrophils by macrophages in the bone marrow also contributes to these circadian changes in CXCL12 expression and HSC circulation 93 . Consistent with this, macrophages modulate Cxcl12 expression by Nes-GFP + cells and HSC retention in the bone marrow 94, 95 . Non-myelinating Schwann cells seem to regulate the niche by regulating TGF-β activation and potentially by secreting other factors 96 . Osteoclasts, or osteoclast activity at the endosteum, may also influence HSC maintenance and bone marrow retention 56, 97, 98 . Many different cell types are likely to directly or indirectly regulate the perivascular HSC niche.
Given the complexity of cell types implicated in the regulation of HSCs, there is no singular niche cell. Rather, the niche integrates the function of multiple participants. It is important to bear in mind that niche composition and niche function may change under different physiological conditions or in response to stress. It is also important to note that many of the Cre recombinase alleles used so far to study niche cells were active during development. Although this was necessary to achieve efficient gene deletion (temporally regulated CreER alleles tend to give much lower levels of recombination) and no abnormalities in development were noted, indirect effects on surrounding cell types and compensatory changes cannot be excluded. Even though endothelial cells and perivascular mesenchymal cells express SCF and CXCL12, conditional deletion of these factors from these cell types may have direct and indirect effects on HSCs.
There may also be long-range signals circulating through the blood that regulate HSC or niche function, perhaps integrating stem-cell activity with overall physiology 99 . These may include hormones that signal reproductive or nutritional status, or even haematopoietic cytokines. For example, thrombopoietin is required for HSC maintenance [100] [101] [102] [103] . The main sites of thrombopoietin synthesis are in the liver and kidney, although it is also synthesized at lower levels by bone marrow stroma 104, 105 . Conditional deletion experiments will be required to determine the physiologically important source or sources of thrombopoietin for HSC maintenance.
There may also be functionally distinct perivascular environments in the bone marrow based on vessel type. Most studies of perivascular niches in the bone marrow have focused on sinusoids because they are the most abundant blood vessels in the bone marrow and most HSCs, MSCs, Scf-expressing cells and Cxcl12-expressing cells are in close proximity to them This conclusion was based on the observation that HSCs were depleted and driven into cycle when NG2-CreER + cells were ablated by treatment with diphtheria toxin. However, these data seem to conflict with the earlier observation that quiescent HSCs are eliminated from the bone marrow when Scf is conditionally deleted using Tie2-Cre and Lepr-Cre, which recombine in endothelial cells and mesenchymal cells that are primarily around sinusoids throughout the bone marrow 20 . It will thus be interesting to determine whether HSCs are depleted when Scf is conditionally deleted using NG2-CreER or whether NG2-CreER is expressed by cells other than periarteriolar cells in the bone marrow. Similarly, it will be important to assess whether Lepr-expressing perivascular cells contribute to arteriolar niches in the bone marrow. In the end, perivascular niches associated with both sinusoids and arterioles may regulate HSC maintenance and quiescence in the bone marrow. Dissecting the diversity in perivascular environments will require Cre alleles that are specifically expressed within distinct perivascular domains to map their functions.
Evidence of HSCs residing within relatively hypoxic domains within the bone marrow 31,107 has partly been based on staining with pimonidazole 31 . Stained HSCs often reside adjacent to sinusoids in the bone marrow and are found next to cells that do not stain with pimonidazole 31 . This suggests that pimonidazole staining does not reflect ambient oxygen or that it is cell-autonomously determined, rather than reflecting a hypoxic environment. Pimonidazole responds to reducing intermediates and may reflect more about the metabolic state of cells than ambient oxygen levels.
Some researchers have interpreted the dependence of HSC maintenance on HIF-1α as suggestive of a hypoxic niche 108 . However, a number of factors other than hypoxia regulate HIF-1α expression. A recent imaging study using a nanoprobe specifically reflective of ambient oxygen found that oxygen tension was lowest around sinusoids and highest near the endosteum 109 . The entire bone marrow space had much lower levels of oxygen compared with vessels entering the bone marrow, a feature that was largely lost when haematopoiesis was ablated by cytotoxic drugs. It is therefore likely that consumption of oxygen during haematopoiesis renders the marrow hypoxic but that no distinct hypoxic region exists at the endosteum.
Distinct haematopoietic progenitors have distinct niches
HSCs reside within a specialized niche that is distinct from the niches that nurture other haematopoietic progenitors. For example, although osteolineage cells do not directly regulate HSC maintenance, they do regulate some B-cell lineage progenitors. Cultures enriched for osteoblasts support B lymphopoiesis and ablation of osteoblastic cells in adult mice acutely depletes some B lymphoid progenitors 40, 110 . Deletion of G s α in osteoblastic cells, which is necessary for parathyroid hormone receptor signalling, markedly depleted pro-and pre-B cells in a way that could be mitigated with IL-7 (ref. . Therefore, some early lymphoid progenitors depend on an osteoblastic niche that is cellularly and functionally distinct from the perivascular niche that maintains HSCs.
Other lineage-restricted niches may also exist. For example, macrophages seem to be crucial for erythroid maturation, and macrophage depletion reduces normal and malignant erythropoiesis 114 . Other cellular components of the erythropoiesis niche will have to be identified to understand the relationship between this niche and HSC and lymphoid progenitor niches.
The approach of conditionally deleting specific niche factors from candidate niche cells and then examining the consequences for stem or progenitor cell maintenance in vivo offers the opportunity to map the niches for each stem cell and restricted progenitor in the haematopoietic system, limited only by the precision of the Cre alleles that are available.
Novel niche factors
In contrast to stem cells in some tissues, HSCs cannot be sustainably expanded in culture. This has impeded our ability to safely and effectively transplant HSCs in certain clinical contexts, such as during gene therapy, in which it would be useful to expand transfected HSCs in culture and verify the quality of the transfected HSCs before transplantation. One possibility why HSCs cannot be expanded in culture is the existence of, so far, unidentified growth factors that are synthesized by the niche in vivo.
Some HSC niche factors have only recently been discovered. The addition of pleiotrophin to culture promotes HSC maintenance 115 and Ptn deficiency is associated with HSC depletion and impaired haematopoietic regeneration after myelosuppression 116 . Pleiotrophin is synthesized by sinusoidal endothelial cells and Cxcl12-expressing perivascular stromal cells, and has a non-cell-autonomous role in promoting HSC function 116 . The Slit receptor Robo4, which is expressed by HSCs and endothelial cells, regulates HSC localization in the bone marrow 117, 118 . The Slit2 ligand is restricted to MSCs and possibly other osteoblast lineage cells. This suggests that pleiotrophin and Robo4-Slit2 are important elements of the perivascular niche. The glycoprotein tenascin-C 119 , osteopontin 120, 121 and non-canonical Wnts 25 have also been reported to positively or negatively influence HSC numbers in the bone marrow and are among a number of factors that bear further characterization in terms of cellular source or role with respect to the niche.
Perspective
Ten years of experimentation has validated the niche concept and answered some first order questions about the molecular and cellular nature of the HSC niche in the bone marrow. The 'parts' list that make up this niche remains incomplete, but with the pace of current work it is likely that additional components will be defined and ambiguity about overlapping cell populations resolved over the next few years. This will make it possible to compare anatomically and developmentally distinct HSC niches that have different functions. The number of HSCs expands daily within the fetal liver but is sustained at nearly constant levels in the bone marrow, at least in the absence of injury. How components of these niches compare may inform methods for achieving HSC expansion. Similarly, comparing homologous niches among species, such as long-lived humans with short-lived mice, may provide insight into mechanisms for preserving the integrity of haematopoiesis under stress or in response to ageing. Finally, comparing niches among tissues will assess whether the mesenchymal and endothelial populations in brain, gut and skin share characteristics and functions with those defined in the bone marrow. Do diverse adult tissues consistently have perivascular niches for stem-cell maintenance? Do regenerative tissues have niches with common mechanisms for preserving self-renewal? Are there common components that can be engineered into niches ex vivo?
With the detail now emerging in our understanding of the bone marrow niche, a number of second order questions can be addressed. Increasingly, niche cells can be genetically tagged or modified, allowing both quantification and molecular manipulation. Coupled with high resolution real-time imaging and well-validated methods to measure haematopoiesis, it is becoming possible to systematically elucidate how the niche responds to stresses or physiological changes to mediate changes at the stem-cell and tissue levels. When stressed by infection, myeloablation or neoplasia, what niche components change in number or function to modify haematopoiesis? Is there a hierarchy of niche components that determine these responses? Can such information allow predictive algorithms that guide specific interventions to achieve desired outcomes?
Another set of questions concerns the manner in which the niche participates in diseases of stem-cell failure, such as aplastic anaemia or neoplasia. The niche may be hostile to normal progenitors in those disease states and, with neoplasia, undergo a facultative response to support altered haematopoiesis 122 . Can changes in the niche be a primary but noncell-autonomous driver of neoplasia in humans as has been suggested by animal models 42, 123, 124 ? The potential for unravelling how the microenvironment participates in normal and disease physiology is at hand and promises new approaches to haematological disorders. ■ cells among spleen colonies. J. Cell. Physiol. 62, 327-336 (1963 
